Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-03 Purchase | 2023-11-06 08:00 am | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 50,000 | $78.81 | $3,940,500 | 3,069,842 (Indirect Direct) | View |
| 2023-08-21 Purchase | 2023-08-23 4:58 pm | CASSAVA SCIENCES INC | SAVA | Barry Richard Director | 18,477 | $16.67 | $307,928 | 293,477 (Indirect) | View |
| 2023-03-06 Purchase | 2023-03-08 4:07 pm | CASSAVA SCIENCES INC | SAVA | Barry Richard Director | 88,841 | $25.81 | $2,292,823 | 275,000 (Indirect) | View |
| 2022-08-23 Purchase | 2022-08-25 4:20 pm | CASSAVA SCIENCES INC | SAVA | Barry Richard Director | 36,159 | $23.79 | $860,223 | 186,159 (Indirect) | View |
| 2020-08-07 Sale | 2020-08-07 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 30,000 | $158.5 | $4,754,972 | 3,129,140 (Direct) | View |
| 2020-05-15 Sale | 2020-05-15 9:02 pm | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 30,000 | $141.26 | $4,237,946 | 3,159,140 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-01 Option Award | 2024-10-01 4:37 pm | N/A 2034-10-01 | CASSAVA SCIENCES INC | SAVA | Barry Richard President & CEO | 600,000 | $0 | 600,000 (Direct) | View |
| 2024-05-09 Option Award | 2024-05-13 4:17 pm | N/A 2034-05-09 | CASSAVA SCIENCES INC | SAVA | Barry Richard Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2024-01-03 Option Award | 2024-04-25 09:15 am | 2024-01-03 2024-05-07 | CASSAVA SCIENCES INC | SAVA | Barry Richard Director | 117,390 | $0 | 645,647 (Indirect) | View |
| 2024-04-23 Exercise | 2024-04-25 09:15 am | N/A N/A | CASSAVA SCIENCES INC | SAVA | Barry Richard Director | 176,085 | $22 | 645,647 (Indirect) | View |
| 2024-04-23 Exercise | 2024-04-25 09:15 am | 2024-01-03 2024-05-07 | CASSAVA SCIENCES INC | SAVA | Barry Richard Director | 117,390 | $0 | 645,647 (Indirect) | View |
| 2024-03-01 Option Award | 2024-03-05 8:00 pm | 2025-03-01 2034-03-01 | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 5,525 | $0 | 3,185,367 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-08 4:06 pm | N/A 2033-05-04 | CASSAVA SCIENCES INC | SAVA | Barry Richard Director | 25,000 | $22.34 | 30,000 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 8:00 pm | 2024-03-06 2033-03-06 | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 4,780 | $0 | 3,133,099 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-08 8:03 pm | 2023-03-07 2032-03-07 | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 8,030 | $0 | 3,133,396 (Direct) | View |
Ownership | 2021-06-14 4:22 pm | N/A N/A | CASSAVA SCIENCES INC | SAVA | Barry Richard Director | 0 | $0 | 150,000 (Indirect) | View |
| 2021-03-03 Option Award | 2021-03-05 8:01 pm | 2022-03-03 2031-03-03 | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 8,244 | $0 | 3,130,884 (Direct) | View |
| 2020-08-10 Ownership | 2021-02-12 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 6,500 | $0 | 3,122,640 (Direct) | View |
| 2020-08-05 Option Award | 2020-08-06 4:36 pm | N/A N/A | MIMEDX GROUP INC. | MDXG | Barry Richard Director | 38,135 | $0 | 3,338,135 (Indirect) | View |
| 2020-02-28 Option Award | 2020-02-28 8:04 pm | 2021-02-28 2030-02-28 | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 5,760 | $0 | 3,192,825 (Direct) | View |